Clinical Trial Update: Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN) [Phase 2]

View source ↗

Summary

Phase 2 trial of avacopan for Crescentic IgA nephropathy (IgA nephropathy) is currently recruiting. Sponsor: Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Avacopan (avacopan)

Snippet

Sponsor: Mayo Clinic | Conditions: IgA Nephropathy (IgAN) | Phase 2 | Status: RECRUITING